Results
3049
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3049 companies
Tianda Pharmaceuticals
Market Cap: HK$350.5m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.15
7D
-4.4%
1Y
-35.7%
DongKoo Bio & Pharma
Market Cap: ₩137.9b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩5,100.00
7D
0%
1Y
-12.2%
Chongqing Lummy Pharmaceutical
Market Cap: CN¥4.8b
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
300006
CN¥4.53
7D
-2.2%
1Y
63.5%
SillaJen
Market Cap: ₩431.0b
Develops and commercializes oncolytic immunotherapy products in South Korea.
A215600
₩3,170.00
7D
-5.9%
1Y
16.5%
HighTide Therapeutics
Market Cap: HK$2.4b
A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.
2511
HK$4.13
7D
22.2%
1Y
353.8%
Sigachi Industries
Market Cap: ₹12.0b
Manufactures and sells microcrystalline cellulose and cellulose powder worldwide.
SIGACHI
₹37.70
7D
20.5%
1Y
-31.9%
UBI Pharma
Market Cap: NT$1.7b
UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.
6562
NT$14.25
7D
1.8%
1Y
-62.3%
Human Stem Cells Institute
Market Cap: ₽4.3b
Public Joint-Stock Company ‘Human Stem Cells Institute’ operates as a biotech company primarily in Russia.
ISKJ
₽59.54
7D
0%
1Y
-32.9%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
FinCanna Capital
Market Cap: CA$5.0m
Does not have significant operations.
CALI.X
CA$0.005
7D
0%
1Y
n/a
Blueberries Medical
Market Cap: CA$7.4m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
0%
1Y
50.0%
Indo-Bangla Pharmaceuticals
Market Cap: ৳1.6b
Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
IBP
৳13.40
7D
-6.3%
1Y
3.9%
HLS Therapeutics
Market Cap: CA$177.4m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$5.72
7D
5.3%
1Y
70.7%
Enorama Pharma
Market Cap: SEK 178.6m
A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.
ERMA
SEK 2.66
7D
-1.5%
1Y
-37.9%
Celyad Oncology
Market Cap: €13.8m
A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.
CYAD
€0.31
7D
-0.3%
1Y
34.3%
FLUENT
Market Cap: US$38.2m
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.
FNT.U
US$0.06
7D
0%
1Y
-64.7%
Lipum
Market Cap: SEK 307.6m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 14.50
7D
9.4%
1Y
19.8%
Cannabis Poland
Market Cap: zł15.3m
Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.
CBD
zł0.31
7D
-0.6%
1Y
-29.8%
Salarius Pharmaceuticals
Market Cap: US$2.4m
Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.
SLRX
US$4.58
7D
-4.6%
1Y
-80.9%
Maravai LifeSciences Holdings
Market Cap: US$679.3m
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$2.60
7D
10.2%
1Y
-70.5%
Dextech Medical
Market Cap: €178.4m
Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.
LQ0
€0.81
7D
7.2%
1Y
110.1%
RedHill Biopharma
Market Cap: US$4.7m
A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
RDHL
US$1.51
7D
18.0%
1Y
-86.1%
Tevogen Bio Holdings
Market Cap: US$174.0m
A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$0.87
7D
-2.0%
1Y
98.8%
Avacta Group
Market Cap: UK£213.8m
Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.
AVCT
UK£0.55
7D
-3.5%
1Y
-23.6%
Foghorn Therapeutics
Market Cap: US$307.0m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$5.15
7D
-2.3%
1Y
-44.4%
Sonnet BioTherapeutics Holdings
Market Cap: US$21.3m
A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.
SONN
US$3.49
7D
11.5%
1Y
-46.5%
Tissue Regenix Group
Market Cap: UK£18.2m
A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.
TRX
UK£0.26
7D
-12.1%
1Y
-57.1%
Ryvu Therapeutics
Market Cap: zł654.3m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł28.30
7D
1.8%
1Y
-47.6%
Tanvex BioPharma
Market Cap: NT$12.2b
A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.
6541
NT$50.30
7D
-4.2%
1Y
-28.8%
Pressure BioSciences
Market Cap: US$4.3k
Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.
PBIO
US$0.0001
7D
0%
1Y
-99.6%
Synthaverse
Market Cap: zł321.3m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł4.54
7D
-3.8%
1Y
-1.8%
BioVaxys Technology
Market Cap: CA$8.8m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.30
7D
0%
1Y
-50.0%
Huaren Pharmaceutical
Market Cap: CN¥4.0b
Produces and sells non-PVC soft bag infusions in China.
300110
CN¥3.40
7D
2.4%
1Y
11.8%
DT&CRO
Market Cap: ₩40.8b
Operates as a full-service CRO provider in South Korea.
A383930
₩3,140.00
7D
0.6%
1Y
-49.0%
Orthocell
Market Cap: AU$281.5m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.
OCC
AU$1.11
7D
-2.2%
1Y
138.7%
Taho Pharmaceuticals
Market Cap: NT$10.1b
A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.
6467
NT$181.00
7D
-5.7%
1Y
n/a